Back to Search Start Over

The Etiologic Landscape of Lymphoproliferation in Childhood: Proposal for a Diagnostic Approach Exploring from Infections to Inborn Errors of Immunity and Metabolic Diseases.

Authors :
Costagliola G
De Marco E
Massei F
Roberti G
Catena F
Casazza G
Consolini R
Source :
Therapeutics and clinical risk management [Ther Clin Risk Manag] 2024 May 16; Vol. 20, pp. 261-274. Date of Electronic Publication: 2024 May 16 (Print Publication: 2024).
Publication Year :
2024

Abstract

Lymphoproliferation is defined by lymphadenopathy, splenomegaly, hepatomegaly, or lymphocytic organ and tissue infiltration. The most common etiologies of lymphoproliferation are represented by infectious diseases and lymphoid malignancies. However, it is increasingly recognized that lymphoproliferative features can be the presenting sign of rare conditions, including inborn errors of immunity (IEI) and inborn errors of metabolism (IEM). Among IEI, lymphoproliferation is frequently observed in autoimmune lymphoproliferative syndrome (ALPS) and related disorders, common variable immunodeficiency (CVID), activated phosphoinositide 3-kinase δ syndrome, and Epstein-Barr virus (EBV)-related disorders. Gaucher disease and Niemann-Pick disease are the most common IEMs that can present with isolated lymphoproliferative features. Notably, other rare conditions, such as sarcoidosis, Castleman disease, systemic autoimmune diseases, and autoinflammatory disorders, should be considered in the differential diagnosis of patients with persistent lymphoproliferation when infectious and malignant diseases have been reasonably ruled out. The clinical features of lymphoproliferative diseases, as well as the associated clinical findings and data deriving from imaging and first-level laboratory investigations, could significantly help in providing the correct diagnostic suspicion for the underlying etiology. This paper reviews the most relevant diseases associated with lymphoproliferation, including infectious diseases, hematological malignancies, IEI, and IEM. Moreover, some practical indications to orient the initial diagnostic process are provided, and two diagnostic algorithms are proposed for the first-level assessment and the approach to persistent lymphoproliferation, respectively.<br />Competing Interests: The authors declare no conflicts of interest in this work.<br /> (© 2024 Costagliola et al.)

Details

Language :
English
ISSN :
1176-6336
Volume :
20
Database :
MEDLINE
Journal :
Therapeutics and clinical risk management
Publication Type :
Academic Journal
Accession number :
38770035
Full Text :
https://doi.org/10.2147/TCRM.S462996